Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.
Piccinelli ML, Garcia CC, Panunzio A, Tappero S, Barletta F, Incesu RB, Tian Z, Luzzago S, Mistretta FA, Ferro M, Saad F, Shariat SF, Graefen M, Briganti A, Terrone C, Antonelli A, Chun FKH, de Cobelli O, Musi G, Karakiewicz PI. Piccinelli ML, et al. Among authors: barletta f. J Surg Oncol. 2024 Aug 25. doi: 10.1002/jso.27795. Online ahead of print. J Surg Oncol. 2024. PMID: 39183540
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer.
Martini A, Gandaglia G, Fossati N, Scuderi S, Bravi CA, Mazzone E, Stabile A, Scarcella S, Robesti D, Barletta F, Cucchiara V, Mirone V, Montorsi F, Briganti A. Martini A, et al. Among authors: barletta f. Eur Urol Oncol. 2021 Feb;4(1):42-48. doi: 10.1016/j.euo.2019.03.006. Epub 2019 Apr 5. Eur Urol Oncol. 2021. PMID: 31411971
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Moschini M, Zamboni S, Rakauskas A, Tian Z, Karakiewicz PI, De Cobelli F, Porpiglia F, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: barletta f. Eur Urol. 2020 Jun;77(6):733-741. doi: 10.1016/j.eururo.2019.09.005. Epub 2019 Sep 21. Eur Urol. 2020. PMID: 31547938
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G, Ploussard G, Valerio M, Marra G, Moschini M, Martini A, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Afferi L, Rakauskas A, Gontero P, Mattei A, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: barletta f. Eur Urol Oncol. 2020 Dec;3(6):739-747. doi: 10.1016/j.euo.2020.07.008. Epub 2020 Aug 23. Eur Urol Oncol. 2020. PMID: 32847747
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.
Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, van den Bergh RCN, Valerio M, Marra G, Kasivisvanathan V, Buchner A, Stief CG, Briganti A, Montorsi F, Tilki D, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Kretschmer A, et al. Among authors: barletta f. Eur Urol Focus. 2021 Nov;7(6):1247-1253. doi: 10.1016/j.euf.2020.09.003. Epub 2020 Sep 19. Eur Urol Focus. 2021. PMID: 32962962
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, Sorce G, Barletta F, Scuderi S, Bravi CA, Cucchiara V, Fossati N, Gandaglia G, Montorsi F, Briganti A. Mazzone E, et al. Among authors: barletta f. Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25. Eur Urol Oncol. 2021. PMID: 33358543 Review.
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
Mazzone E, Stabile A, Sorce G, Pellegrino F, Barletta F, Motterle G, Scuderi S, Cirulli GO, Cucchiara V, Brembilla G, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Guccini I, Briganti A. Mazzone E, et al. Among authors: barletta f. Urol Oncol. 2021 Nov;39(11):784.e1-784.e9. doi: 10.1016/j.urolonc.2021.03.013. Epub 2021 Apr 15. Urol Oncol. 2021. PMID: 33865687
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection.
Rosiello G, Gandaglia G, Scuderi S, Barletta F, Fossati N, Stabile A, Gallina A, Mazzone E, Vitale LM, Pellegrino A, Bravi C, Martini A, Cucchiara V, Karakiewicz PI, Mottrie A, Briganti A, Montorsi F. Rosiello G, et al. Among authors: barletta f. Eur Urol Focus. 2022 Mar;8(2):431-437. doi: 10.1016/j.euf.2021.03.026. Epub 2021 Apr 18. Eur Urol Focus. 2022. PMID: 33879394
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Necchi A, Martini A, Raggi D, Cucchiara V, Colecchia M, Lucianò R, Villa L, Mazzone E, Basile G, Scuderi S, Pederzoli F, Bandini M, Barletta F, Larcher A, Capitanio U, Salonia A, Briganti A, Ross JS, Messina A, Montorsi F. Necchi A, et al. Among authors: barletta f. Urol Oncol. 2022 Jan;40(1):10.e1-10.e6. doi: 10.1016/j.urolonc.2021.05.014. Epub 2021 Jun 17. Urol Oncol. 2022. PMID: 34147313
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A. Bravi CA, et al. Among authors: barletta f. Eur Urol Oncol. 2022 Jun;5(3):285-295. doi: 10.1016/j.euo.2021.06.003. Epub 2021 Jun 24. Eur Urol Oncol. 2022. PMID: 34176768
230 results